Search results for: hospital

Practicing in Rural Settings Offers Slower Pace, Personal Satisfaction for Many Rheumatologists

Kurt Ullman | November 1, 2012

Outside of urban areas, rheumatologists enjoy better quality of life, but fewer professional interactions

Rheumatology Drug Updates: Apremilast, Golimumab, and More

Michele B. Kaufman, PharmD, BCGP | November 1, 2012

Information on new approvals and medication safety rheumatologists need to know

Tech Talk: New Platform Aims to Make Telephone Communication Simpler

Thomas R. Collins | November 1, 2012

MedXCom system helps physicians better manage their phone calls with patients

Rheumatologists Seek Public Vote for Research Grant Award

Michael O’Neal | October 17, 2012

Brigham and Women’s docs compete for BRIght Futures Prize for personalized medicine research

Fellow’s Forum Case Report: True Vasculitis or Vasculitis Mimic?

Reeti K. Joshi, MD, Richa Gupta, MD, Hyon Ju Park, MD, Christine Pham, MD, and Leslie Kahl, MD | October 1, 2012

Rheumatologists face the emerging picture of cocaine and levamisole-associated vasculopathy in clinical practice

How Microbes, Mycobacteria, and Metastases May Alter the Way We Look at Rheumatic Diseases

Simon M. Helfgott, MD | October 1, 2012

Studying the relationships between microbes and their hosts, the role for Bacille Calmette Guerin (BCG) as a vaccine for Type I diabetes, and emotional stress and bone metastases

Nomenclature, Semantics, Jargon, Lingo, Eponyms, Etymology, and Terminology in Rheumatology

Prakash Pispati | October 1, 2012

Why rheumatologists must coin simple, comprehensible terms for what we read, speak and write to our patients

The ACR/ARHP Annual Meeting Edition

Staff | October 1, 2012

An in-depth look at Washington, D.C.—the host city for the American College of Rheumatology’s annual meeting—and specialized sessions to help rheumatologists navigate the healthcare environment and foster a thriving practice

Coding Corner Question: October

Staff | October 1, 2012

Test your coding knowledge

Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease

Thomas R. Collins | October 1, 2012

Research shows that a serum from goats might be helpful in combating diffuse cutaneous systemic sclerosis (SSc)